Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows a revision stamp of v3.6.3, replacing the previous v3.6.2, indicating an updated version of the page.
    Difference
    0.0%
    Check dated 2026-07-03T14:50:35.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.0 to v3.6.2. This appears to be a minor internal version update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-06-26T12:42:14.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added user-focused sections to aid participation and understanding (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updated the page revision to v3.6.0, with the Intervention/Treatment heading added. Removed the prior formatting of the Intervention/Treatment heading (Intervention / Treatment) and the older revision label (Revision: v3.5.5).
    Difference
    0.1%
    Check dated 2026-06-12T04:18:02.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a new revision tag 'Revision: v3.5.5' replacing the previous 'Revision: v3.5.4', indicating a content/system revision.
    Difference
    0.0%
    Check dated 2026-06-05T00:08:30.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4 on the page, indicating a routine update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-05-21T16:28:38.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District, Taiwan to Taoyuan, Taiwan, keeping the same postal code. This clarifies the exact city-level location for that recruitment site.
    Difference
    0.0%
    Check dated 2026-05-07T09:59:41.000Z thumbnail image

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.